{"product_id":"textbook-of-pharmacoepidemiology-isbn-9780470029244","title":"Textbook of Pharmacoepidemiology","description":"The \u003cb\u003e\u003ci\u003eTextbook of Pharmacoepidemiology\u003c\/i\u003e\u003c\/b\u003e provides a streamlined text for evaluating the safety and effectiveness of medicines. It includes a brief introduction to pharmacoepidemiology as well as sections on data sources, methodology and applications. Each chapter includes key points, case studies and essential references.  \u003cul\u003e \u003cli\u003eOne-step resource to gain understanding of the subject of pharmacoepidemiology at an affordable price\u003c\/li\u003e \u003cli\u003eGives a perspective on the subject from academia, pharmaceutical industry and regulatory agencies\u003c\/li\u003e \u003cli\u003eDesigned for students with basic knowledge of epidemiology and public health\u003c\/li\u003e \u003cli\u003eIncludes many case studies to illustrate pharmacoepidemiology in real clinical setting  \u003c\/li\u003e \u003c\/ul\u003e  List of Contributors.  \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003eAcknowledgments.\u003c\/p\u003e \u003cp\u003eAcknowledgments from \u003ci\u003ePharmacoepidemiology, Fourth Edition\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION I INTRODUCTION TO PHARMACOEPIDEMIOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. What is Pharmacoepidemiology? (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e2. Study Designs Available for Pharmacoepidemiology Studies (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e3. Sample Size Considerations for Pharmacoepidemiology Studies (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e4. Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies (\u003ci\u003eSean Hennessy\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e5. When Should One Perform Pharmacoepidemiology Studies? (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e6. Views from Academia, Industry, and Regulatory Agencies (\u003ci\u003eLeanne K. Madre, Robert M. Califf, Robert F. Reynolds, Peter Arlett, and Jane Moseley\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION II SOURCES OF PHARMACOEPIDEMIOLOGY DATA.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7. Spontaneous Reporting in the United States (\u003ci\u003eSyed Rizwanuddin Ahmad, Norman S. Marks, and Roger A. Goetsch\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e8. Global Drug Surveillance: The WHO Programme for International Drug Monitoring (\u003ci\u003eI. Ralph Edwards, Sten Olsson, Marie Lindquist, and Bruce Hugman\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e9. Case–Control Surveillance (\u003ci\u003eLynn Rosenberg, Patricia F. Coogan, and Julie R. Palmer\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e10. Prescription-Event Monitoring (\u003ci\u003eSaad A.W. Shakir\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e11. Overview of Automated Databases in Pharmacoepidemiology (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e12. Examples of Automated Databases (\u003ci\u003eAndy Stergachis, Kathleen W. Saunders, Robert L. Davis, Stephen E. Kimmel, Rita Schinnar, K. Arnold Chan, Deborah Shatin, Nigel S.B. Rawson, Sean Hennessy, Winanne Downey, MaryRose Stang, Patricia Beck, William Osei, Hubert G. Leufkens, Thomas M. MacDonald, and Joel M. Gelfand\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e13. Other Approaches to Pharmacoepidemiology Studies (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e14. How Should One Perform Pharmacoepidemiology Studies? Choosing Among the Available Alternatives (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e15. Validity of Pharmacoepidemiologic Drug and Diagnosis Data (\u003ci\u003eSuzanne L. West, Brian L. Strom, and Charles Poole\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION III SPECIAL ISSUES IN PHARMACOEPIDEMIOLOGY METHODOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e16. Bias and Confounding in Pharmacoepidemiology (\u003ci\u003eIlona Csizmadi and Jean-Paul Collet\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e17. Determining Causation from Case Reports (\u003ci\u003eJudith K. Jones\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e18. Molecular Pharmacoepidemiology (\u003ci\u003eStephen E. Kimmel\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e19. Bioethical Issues in Pharmacoepidemiologic Research (\u003ci\u003eKevin Haynes, Jason Karlawish, and Elizabeth B. Andrews\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e20. The Use of Randomized Controlled Trials for Pharmacoepidemiology Studies (\u003ci\u003eSamuel M. Lesko and Allen A. Mitchell\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e21. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e22. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals (\u003ci\u003eKevin A. Schulman, Henry A. Glick, and Daniel Polsky\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e23. Using Quality-of-Life Measurements in Pharmacoepidemiologic Research (\u003ci\u003eHolger Schünemann, Gordon H. Guyatt, and Roman Jaeschke\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e24. The Use of Meta-analysis in Pharmacoepidemiology (\u003ci\u003eCarin J. Kim and Jesse A. Berlin\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e25. Patient Adherence to Prescribed Drug Dosing Regimens in Ambulatory Pharmacotherapy (\u003ci\u003eJohn Urquhart and Bernard Vrijens\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e26. Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis (\u003ci\u003eSamy Suissa\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION IV SPECIAL APPLICATIONS OF PHARMACOEPIDEMIOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e27. Special Applications of Pharmacoepidemiology (\u003ci\u003eDavid Lee, Sumit R. Majumdar, Helene Levens Lipton, Stephen B. Soumerai, Sean Hennessy, Robert L. Davis, Robert T. Chen, Roselie A. Bright, Allen A. Mitchell, David J. Graham, David W. Bates, and Brian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e28. The Future of Pharmacoepidemiology (\u003ci\u003eBrian L. Strom and Stephen E. Kimmel\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eAppendix A Sample Size Tables.\u003c\/p\u003e \u003cp\u003eAppendix B Glossary.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e  \"…a useful textbook for upper-level undergraduate, graduate, and postdoctoral fellows in pharmacy, medical, and public health programs.\" (\u003ci\u003eThe Annals of Pharmacotherapy\u003c\/i\u003e, June 2007)  \u003cp\u003e\"This is a major text with far-reaching impact…recommended for all courses in public health or pharmacology…\" (\u003ci\u003eElectric Review\u003c\/i\u003e, March\/April 2007)\u003c\/p\u003e  \u003cb\u003eBrian L. Strom\u003c\/b\u003e, University of Pennsylvania School of Medicine, USA.   \u003cp\u003e\u003cb\u003eStephen E. Kimmel\u003c\/b\u003e, Associate Professor of Medicine and Epidemiology, University of Pennsylvania School of Medicine, USA.\u003c\/p\u003e  In recent years the public has clearly become markedly more interested in assuring the safety and effectiveness of its medicines. It is also critical that available medicines are used optimally, by both health care practitioners and patients. We need to know the extent to which an intervention does what it is really intended to do, under routine circumstances rather than ideal conditions, for those who receive it. Appropriate and valid pharmacoepidemiology methods are central to evaluating the safety and effectiveness of medicines and their use. This textbook is the abridged version of Brian Strom's Pharmacoepidemiology Fourth Edition, and presents the essential material for such evaluations.  \u003cp\u003eIt provides methods, details of potential data sources, and information about evaluating the results and drawing conclusions. The layout and easy to read style will provide an accessible introduction to pharmacoepidemiology as well as a reference source for academics, public health practitioners, regulatory agencies, the pharmaceutical industry and the law.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47990146760933,"sku":"NP9780470029244","price":191.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470029244.jpg?v=1761786681","url":"https:\/\/k12savings.com\/es\/products\/textbook-of-pharmacoepidemiology-isbn-9780470029244","provider":"K12savings","version":"1.0","type":"link"}